Zika Virus Polypeptides
AssigneeMayo Foundation for Medical Education and Research
InventorsGregory A. POLAND, Inna G. OVSYANNIKOVA, Richard B. KENNEDY
Life of this patent
Estimating the term…
Abstract
This document provides methods and materials related to selected Zika virus polypeptides. For example. vaccine compositions that contain one or more selected Zika virus polypeptides provided herein and that have the ability to increase immune responses against flaviviruses such as Zika viruses within a mammal (e.g., a human) are provided.
Claims17
A substantially pure polypeptide consisting essentially of or consisting of the amino acid sequence set forth in any one of SEQ ID NOs:1-17.
A composition comprising at least four polypeptides, wherein each of said at least four polypeptides is a polypeptide consisting essentially of or consisting of the amino acid sequence set forth in any one of SEQ ID NOs:1-17.
A method for increasing an immune response against a flavivirus in a mammal, wherein said method comprises administering to said mammal a composition comprising a polypeptide consisting essentially of or consisting of the amino acid sequence set forth in any one of SEQ ID NOs:1-17.
Dependencies are inferred from the claim text.